Investors

688222

RMB

Highest
Lowest
Volume
Amount

Up to Beijing time. There is 15-minute delay in the quoted price.

Announcements

Interim Announcement

Annual Report

Investors
Interim Announcement

Interim Announcement

The Board Office is in charge of the information disclosure and investor relations. The secretary of the board is Shiwei Geng.

Tel:

+86 28 85197385

E-mail:

investors@hitgen.com

info@hitgen.com

Sites: HitGen Inc.

Building C2, NO.8, Huigu 1st East Road
Tianfu International Bio-Town,
Shuangliu District, Chengdu City,
Sichuan Province,P.R. China

Tel : +86-28-8519-7385

HitGen Pharmaceuticals Inc.(US Subsidiary)

Tel : +1-(508)-840-9646

Vernalis (R&D) Limited (UK Subsidiary)

Granta Park,Great Abington
Cambridge,CB21 6GB
United Kingdom

Tel : +44(0)1223-895555

Contact: Business Inquiry : bd@hitgen.com; Investor Relations : investors@hitgen.com; Media : media@hitgen.com; Career and Jobs : human.resources@hitgen.com

We use cookies to provide a better web experience.
By using our site, you acknowledge our use of cookies and please read our Cookie Notice for More information

↑